Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2020-04-11
2022-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Northeast COVID-19 and Pregnancy Study Group
NCT04462367
COVID-19 and Pregnancy Outcomes
NCT04416373
Obstetric and Perinatal Outcomes of Women With COVID-19
NCT04369859
Clinical Study of Pregnant Women With COVID-19
NCT04701944
Prognosis in Pregnant With COVID-19
NCT04409249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Covid-19 HC patients
Pregnant women hospitalized with symptoms and diagnosis of SARS-CoV-2 at HC-FMUSP.
SARS-CoV-2 serology
Serology test of SARS-CoV-2 for pregnant women
Delivery patients
Asymptomatic pregnant women that tested SARS-CoV-2 serology (positive or negative serology) at the delivery time at Universitarian Hospital HU-USP and HC-FMUSP.
SARS-CoV-2 serology
Serology test of SARS-CoV-2 for pregnant women
Prenatal patients
Pregnant women that performs prenatal care in Universitarian Hospital HU-USP or HC-FMUSP with diagnosis of SARS-CoV-2.
SARS-CoV-2 serology
Serology test of SARS-CoV-2 for pregnant women
Negative serology patients
Pregnant women that performs prenatal care with symptoms and tested serology/swab negative for SARS-CoV-2.
SARS-CoV-2 serology
Serology test of SARS-CoV-2 for pregnant women
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SARS-CoV-2 serology
Serology test of SARS-CoV-2 for pregnant women
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Asymptomatic pregnant women for SARS-CoV-2 during pregnancy and hospitalized for delivery at HU-USP.
* Pregnant women diagnosed with SARS-CoV-2 prior to delivery and who, after the quarantine period, followed prenatal care and delivered at the HU-USP or HCFMUSP.
Exclusion Criteria
* Withdrawal of pregnant woman to continue in the study.
17 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rossana P Francisco, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculdade de Medicina da Universidade de São Paulo - FMUSP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rossana P Fracisco
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30270820.3.0000.0068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.